114 related articles for article (PubMed ID: 38529954)
1. Efficacy of a Digital Diabetes Logbook for People With Type 1, Type 2, and Gestational Diabetes: Results From a Multicenter, Open-Label, Parallel-Group, Randomized Controlled Trial.
Ehrmann D; Hermanns N; Finke-Gröne K; Roos T; Kober J; Schäfer V; Krichbaum M; Haak T; Ziegler R; Heinemann L; Rieger C; Bingol E; Kulzer B; Silbermann S
J Diabetes Sci Technol; 2024 Mar; ():19322968241239870. PubMed ID: 38529954
[TBL] [Abstract][Full Text] [Related]
2. Health care effects and medical benefits of a smartphone-based diabetes self-management application: study protocol for a randomized controlled trial.
Ehrmann D; Eichinger V; Vesper I; Kober J; Kraus M; Schäfer V; Hermanns N; Kulzer B; Silbermann S
Trials; 2022 Apr; 23(1):282. PubMed ID: 35410241
[TBL] [Abstract][Full Text] [Related]
3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
4. Mobile App for Improved Self-Management of Type 2 Diabetes: Multicenter Pragmatic Randomized Controlled Trial.
Agarwal P; Mukerji G; Desveaux L; Ivers NM; Bhattacharyya O; Hensel JM; Shaw J; Bouck Z; Jamieson T; Onabajo N; Cooper M; Marani H; Jeffs L; Bhatia RS
JMIR Mhealth Uhealth; 2019 Jan; 7(1):e10321. PubMed ID: 30632972
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of a Digital Health Tool for Titration of Basal Insulin in People With Type 2 Diabetes: Rationale and Design of a Randomized Controlled Trial.
Hermanns N; Ehrmann D; Finke-Gröne K; Roos T; Freckmann G; Kulzer B
J Diabetes Sci Technol; 2023 Jan; ():19322968221148756. PubMed ID: 36602040
[TBL] [Abstract][Full Text] [Related]
6. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
Akova M; Unal S
Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
[TBL] [Abstract][Full Text] [Related]
7. Use of smartphone application versus written titration charts for basal insulin titration in adults with type 2 diabetes and suboptimal glycaemic control (My Dose Coach): multicentre, open-label, parallel, randomised controlled trial.
Hermanns N; Ehrmann D; Finke-Groene K; Krichbaum M; Roos T; Haak T; Freckmann G; Kulzer B
Lancet Reg Health Eur; 2023 Oct; 33():100702. PubMed ID: 37954005
[TBL] [Abstract][Full Text] [Related]
8. Supported Telemonitoring and Glycemic Control in People with Type 2 Diabetes: The Telescot Diabetes Pragmatic Multicenter Randomized Controlled Trial.
Wild SH; Hanley J; Lewis SC; McKnight JA; McCloughan LB; Padfield PL; Parker RA; Paterson M; Pinnock H; Sheikh A; McKinstry B
PLoS Med; 2016 Jul; 13(7):e1002098. PubMed ID: 27458809
[TBL] [Abstract][Full Text] [Related]
9. Immediate and Long-Term Effects of an 8-Week Digital Mental Health Intervention on Adults With Poorly Managed Type 2 Diabetes: Protocol for a Randomized Controlled Trial.
Boucher E; Moskowitz JT; Kackloudis GM; Stafford JL; Kwok I; Parks AC
JMIR Res Protoc; 2020 Aug; 9(8):e18578. PubMed ID: 32749998
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of Personalized Diabetes Self-care Using an Electronic Medical Record-Integrated Mobile App in Patients With Type 2 Diabetes: 6-Month Randomized Controlled Trial.
Lee EY; Cha SA; Yun JS; Lim SY; Lee JH; Ahn YB; Yoon KH; Hyun MK; Ko SH
J Med Internet Res; 2022 Jul; 24(7):e37430. PubMed ID: 35900817
[TBL] [Abstract][Full Text] [Related]
11. Effect of intensive lifestyle intervention on bodyweight and glycaemia in early type 2 diabetes (DIADEM-I): an open-label, parallel-group, randomised controlled trial.
Taheri S; Zaghloul H; Chagoury O; Elhadad S; Ahmed SH; El Khatib N; Amona RA; El Nahas K; Suleiman N; Alnaama A; Al-Hamaq A; Charlson M; Wells MT; Al-Abdulla S; Abou-Samra AB
Lancet Diabetes Endocrinol; 2020 Jun; 8(6):477-489. PubMed ID: 32445735
[TBL] [Abstract][Full Text] [Related]
12. A prospective, randomized, single-blinded, crossover trial to investigate the effect of a wearable device in addition to a daily symptom diary for the remote early detection of SARS-CoV-2 infections (COVID-RED): a structured summary of a study protocol for a randomized controlled trial.
Brakenhoff TB; Franks B; Goodale BM; van de Wijgert J; Montes S; Veen D; Fredslund EK; Rispens T; Risch L; Dowling AV; Folarin AA; Bruijning P; Dobson R; Heikamp T; Klaver P; Cronin M; Grobbee DE;
Trials; 2021 Jun; 22(1):412. PubMed ID: 34158099
[TBL] [Abstract][Full Text] [Related]
13. A Phase 3 Open-label, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Intravenously Administered Ravulizumab Compared with Best Supportive Care in Patients with COVID-19 Severe Pneumonia, Acute Lung Injury, or Acute Respiratory Distress Syndrome: A structured summary of a study protocol for a randomised controlled trial.
Smith K; Pace A; Ortiz S; Kazani S; Rottinghaus S
Trials; 2020 Jul; 21(1):639. PubMed ID: 32660611
[TBL] [Abstract][Full Text] [Related]
14. Comparing Two Commercially Available Diabetes Apps to Explore Challenges in User Engagement: Randomized Controlled Feasibility Study.
Maharaj A; Lim D; Murphy R; Serlachius A
JMIR Form Res; 2021 Jun; 5(6):e25151. PubMed ID: 34132640
[TBL] [Abstract][Full Text] [Related]
15. An automated structured education intervention based on a smartphone app in Chinese patients with type 1 diabetes: a protocol for a single-blinded randomized controlled trial.
Huang F; Wu X; Xie Y; Liu F; Li J; Li X; Zhou Z
Trials; 2020 Nov; 21(1):944. PubMed ID: 33225982
[TBL] [Abstract][Full Text] [Related]
16. Improving Mild to Moderate Depression With an App-Based Self-Guided Intervention: Protocol for a Randomized Controlled Trial.
Beintner I; Kerber A; Dominke C; Voderholzer U
JMIR Res Protoc; 2023 Oct; 12():e46651. PubMed ID: 37878374
[TBL] [Abstract][Full Text] [Related]
17. Impact of a smartphone application (KAIA COPD app) in combination with Activity Monitoring as a maintenance prOgram following PUlmonary Rehabilitation in COPD: the protocol for the AMOPUR Study, an international, multicenter, parallel group, randomized, controlled study.
Spielmanns M; Boeselt T; Huber S; Kaur Bollinger P; Ulm B; Peckaka-Egli AM; Jarosch I; Schneeberger T; Schoendorf S; Gloeckl R; Koczulla AR
Trials; 2020 Jul; 21(1):636. PubMed ID: 32653025
[TBL] [Abstract][Full Text] [Related]
18. Use of professional-mode flash glucose monitoring, at 3-month intervals, in adults with type 2 diabetes in general practice (GP-OSMOTIC): a pragmatic, open-label, 12-month, randomised controlled trial.
Furler J; O'Neal D; Speight J; Blackberry I; Manski-Nankervis JA; Thuraisingam S; de La Rue K; Ginnivan L; Doyle R; Holmes-Truscott E; Khunti K; Dalziel K; Chiang J; Audehm R; Kennedy M; Clark M; Jenkins A; Lake AJ; Januszewski AS; Catchpool M; Liew D; Clarke P; Best J
Lancet Diabetes Endocrinol; 2020 Jan; 8(1):17-26. PubMed ID: 31862147
[TBL] [Abstract][Full Text] [Related]
19. A Web-Based Mental Health Intervention to Improve Social and Occupational Functioning in Adults With Type 2 Diabetes (The Springboard Trial): 12-Month Outcomes of a Randomized Controlled Trial.
Baldwin PA; Sanatkar S; Clarke J; Fletcher S; Gunn J; Wilhelm K; Campbell L; Zwar N; Harris M; Lapsley H; Hadzi-Pavlovic D; Christensen H; Proudfoot J
J Med Internet Res; 2020 Dec; 22(12):e16729. PubMed ID: 33258790
[TBL] [Abstract][Full Text] [Related]
20. Yoga Programme for Type 2 Diabetes Prevention (YOGA-DP) Among High-Risk People in India: A Multicenter Feasibility Randomized Controlled Trial.
Chattopadhyay K; Mishra P; Singh K; Singh K; Harris T; Hamer M; Greenfield SM; Manjunath NK; Nair R; Mukherjee S; Tandon N; Lewis SA; Kinra S; Prabhakaran D;
Diabetes Ther; 2023 Jul; 14(7):1137-1154. PubMed ID: 37002475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
